Lung Cancer Screening Software Market (CAGR +19.63%) Drivers, Restraints, Size, Share Analysis and Prominent Players PENRAD TECHNOLOGIES, INC., Kheiron Medical Technologies, Volpara Solutions Limited, Thynk Health, CRA Health LLC

Lung Cancer Screening Software Market research report is very much essential in many ways to grow the business and thrive in the market. The market transformations are highlighted here which occur because of the moves of key players and brands like developments, product launches, joint ventures, merges and accusations that in turn changes the view of the global face of Healthcare IT industry. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Global Lung Cancer Screening Software Market research report is a vital document in planning business objectives or goals.

Global lung cancer screening software market is expected to register a healthy CAGR of 19.63% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the various clinical trial initiated for cancer treatment requiring frequent diagnosis and screening to test the effectiveness of the trial.

Get Free Sample Analysis of This Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-screening-software-market

Lung cancer screening software can be defined as the software offering, which is designed to automate the workflow of healthcare facilities by collecting all of the diagnostic results gathered from CT, X-Ray and MRI machines. This results in enhancement of the workflow operability in these facilities. The implementation of this software helps in better patient tracking, assessment of disease stage, next step of action, reporting and keeping a systemized data of patient information.

Leading Players:

PENRAD TECHNOLOGIES, INC.;
Eon;
Koninklijke Philips N.V.;
Kheiron Medical Technologies;
Volpara Solutions Limited;
Thynk Health;
CRA Health LLC;
ProVation Medical, Inc.;
Nuance Communications, Inc.;
Siemens Healthcare GmbH;
CureMetrix, Inc.;
MyCareWare Inc.;
MobileODT;
MRS Systems, Inc.;
Lungview and Vital Images

Key Developments in the Market:

In November 2018, Eon announced that they will provide 170 "EonDirect LCSR (Lung Cancer Screening Registry)" software licenses amounting upto USD 1 million to provide radiology centers, clinics and hospital facilities with enhanced screening service in comparison to the conventional manual tracking utilized. EonDirect registers and tracks patients for lung cancer screening through its cloud-based application system keeping a systematic track of the patient data

In November 2018, Lungview announced the launch of an upgraded lung cancer screening software with the availability of "LungView Luminary" on the new website. The upgraded tracking system helps physicians in keeping a record of patients, and following-up with them on their screening programs. The upgraded version provides optional node tracking, incidental findings tracking and dose information

Competitive Analysis:

Global lung cancer screening software market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of lung cancer screening software market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Segmentation: Global Lung Cancer Screening Software Market

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia-Pacific
South America
Brazil
Rest of South America
Middle East and Africa
South Africa
Rest of Middle East and Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-lung-cancer-screening-software-market

Market Drivers

Increasing prevalence of lung cancer cases globally is expected to boost the growth of the market
Increasing awareness regarding the benefits of early diagnosis and frequent screening acts as a market driver
Variety of government initiatives undertaken to implement screening programs for various diseases can also drive the market growth
Multiple benefits such as identification, tracking, enrollment, patient data integration, analytics, communication with physicians helps in better organization of workflow in healthcare facilities which can fuel the growth of this market

Market Restraints

Lack of awareness regarding the screening programs and its benefits in developing regions of the world is expected to hinder the growth of the market
Dearth of technically knowledgeable professionals for cancer diagnosis is expected to restrict the market growth
Lack of funding and other resources from various regions for cancer and associated disorders can also hamper the market growth

WHY CHOOSE US

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today's world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients' success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service

Want Full Report? Enquire Here: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lung-cancer-screening-software-market

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization and Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.